Influenza A virus vaccine H5N2 intranasal - BioDiem

Drug Profile

Influenza A virus vaccine H5N2 intranasal - BioDiem

Alternative Names: GPO Avian Flu Vaccine; GPO H5N2 PLAIV; Intranasal H5N2 vaccine - Institute of Experimental Medicine of the Russian Academy of Medical Sciences/Biodiem; LAIV H5N2 pandemic vaccine; LAIV H5N2/A/Len/17; Pandemic LAIV H5N2

Latest Information Update: 10 Mar 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Institute of Experimental Medicine of the Russian Academy of Medical Sciences
  • Developer Government Pharmaceutical Organization; Institute of Experimental Medicine of the Russian Academy of Medical Sciences; Mahidol University; World Health Organization
  • Class Influenza A vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza virus infections

Most Recent Events

  • 10 Mar 2016 Phase-II development in Influenza A virus H5N2 subtype is ongoing in Thailand (Intranasal)
  • 01 Jan 2013 Phase-II clinical trials in Influenza A virus H5N2 subtype in Thailand (Intranasal)
  • 01 May 2012 Phase-I clinical trials for Influenza A virus H5N2 subtype in Thailand (Intranasal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top